New stock news | Bullish on Doctor Cloud Healthcare from prospectus: The outline of AI-driven medical health technology platform is emerging.

When the market is still accustomed to understanding Good Doctor Cloud Healthcare as a "traditional internet medical platform" or even a "traditional pharmaceutical distribution channel," the company's submission of listing application materials to the Hong Kong Stock Exchange has actually presented a different business profile. From a financial perspective, the company's revenue in 2023, 2024, and 2025 is 30.65 billion yuan, 32.64 billion yuan, and 38.23 billion yuan respectively, showing continuous growth over the past three years. The adjusted pre-tax profit for 2025 is 101 million yuan, an increase of 8.74% from 92.85 million yuan in 2024. If one only looks at these financial data, they would see a steadily growing grassroots medical service platform. However, looking further into the business structure, system capabilities, and product evolution, one would realize that the company has moved beyond the old label of a "single online service platform" and entered a new phase with more technological and platform attributes. The most notable variable among them is AI. 1. Market perception of Good Doctor Cloud Healthcare may still be stuck in the previous stage Good Doctor Cloud Healthcare is most easily labeled as an "internet medical platform" or "grassroots medical traffic platform" by outsiders. This perception is not unfounded the company has indeed long focused on providing online and platform services and solutions to grassroots medical terminals. However, if one only stays at this level, they are likely to overlook the structural changes that have occurred in recent years. According to the prospectus, the company has developed three mature business segments around grassroots medical terminals: direct supply and distribution of pharmaceuticals, specialized disease diagnosis and treatment solutions, and diagnostic testing solutions. These three segments do not exist in isolation but operate synergistically to provide a one-stop service and solution for a large number of grassroots medical terminals in the sinking Chinese market. The prospectus explicitly states that the services are "mainly provided online through the APP" and that the "backend of the cloud-deployed APPs are interconnected," enabling the use of big data and data analysis technologies to understand customer purchasing behavior and demands. This means that the company's foundation is not a single-point business model but a grassroots medical service platform characterized by an APP entry point and multi-business collaboration. Furthermore, the business map in the prospectus mentions keywords such as HIS, compliance systems, POCT, ICL, and health management, indicating that the company's goal is not just selling drugs or providing single online medical services but constructing a more complete service chain around grassroots medical terminals. The reason why the market easily underestimates companies like this is straightforward: during a transformational period, companies are most likely to be in a situation where "old labels still exist, but new capabilities have not been fully recognized." While the market sees the main business on the financial statements, what really determines the next stage of valuation logic is often the new capabilities that have not been fully quantified yet. This is where Good Doctor Cloud Healthcare currently stands. 2. AI is not a decoration but a crucial variable in platform upgrade If we were to find the most representative content of the "new reality" from the prospectus, AI is undoubtedly one of the core clues. The company's AI-enabled Good Doctor Diagnosis Support System is not a standalone fringe product but part of a strategic cooperation between the company and Hangzhou Whole Medical Science and Technology Co., Ltd. Whole Medical Science provides the company with an embedded "Whole Medical Model" medical AI-driven platform for use in doctor and patient services; based on this, the company has launched the AI Good Doctor Diagnosis Support System for grassroots medical institutions. From a product definition perspective, this system goes beyond the scope of ordinary AI tools: it is designed as a "lightweight cloud software solution" that can be accessed through multiple interconnected client portals, assisting grassroots medical institutions in rapidly improving their diagnostic capabilities. The platform integrates HIS, compliance systems, and AI medical assistants specializing in general practice, traditional Chinese medicine, and clinical laboratory areas, providing grassroots medical terminals with digitized intelligent support throughout the entire business process, including: Pre-diagnosis: AI-enabled electronic medical record generation During diagnosis: AI-assisted diagnosis, intelligent prescription review Post-diagnosis: Intelligent health management In other words, for Good Doctor Cloud Healthcare, AI is not just a marketing concept embellished on the existing platform but a system that rewrites the service logic of the platform evolving from mere transaction and service connectivity to being a participant in the diagnosis and treatment process, improving efficiency and standardization. However, the prospectus does not separately disclose the scale of AI business revenue. Currently, two points can be directly confirmed: firstly, the prospectus notes that the "other" revenue in 2025 mainly includes revenue from the AI Good Doctor Diagnosis Support System; secondly, the AI Good Doctor Diagnosis Support System has formed clear coverage, order, and contract amount data. This indicates that AI has become a significant variable in the company's business structure upgrade and has started to contribute to revenue and orders. 3. From single online services to multi-scenario collaboration, platform boundaries are expanding What is truly worth paying attention to is not just that the company "has AI" but where AI is embedded. From the prospectus, the platform boundaries of Good Doctor Cloud Healthcare have expanded from early online services to multiple critical grassroots medical segments. Firstly, is the platformization capability of the APP. The company explicitly states that its services are primarily provided online through the APP, and the backend of different business units' APPs are interconnected. This architecture determines that the company has accumulated not just single business data but multi-business, multi-scenario, and multi-role data and service capabilities. Secondly, is the integration of hospital-side digitalization with HIS. The AI Good Doctor Diagnosis Support System is not an external tool floating above grassroots medical terminals but directly integrates with HIS and compliance systems. This means that its goal is not to be an isolated "AI Q&A box" but to enter into the diagnosis, medical records, prescription review, and operational management processes. Thirdly, is the collaboration in diagnostic testing. The prospectus mentions POCT and ICL in several places. The company's business already includes diagnostic testing solutions, and its upstream suppliers include manufacturers of POCT devices and related consumables, independent clinical laboratories (ICL), etc. This means that its AI capabilities do not exist independently of the testing system but may be linked to existing testing, clinical support, and report interpretation capabilities. Fourthly, is health management and post-diagnostic extension. The functionality of the AI system is not limited to assisting in diagnosis during the consultation but extends to intelligent health management post-diagnosis. This is crucial because it indicates that the company is attempting to embed AI in the entire patient management process rather than just in a one-time consultation scenario. From the perspective of industry policies, this direction aligns with the encouragement of medical AI deployment by regulations. According to the "Reference Guidelines for the Application Scenarios of Artificial Intelligence in the Health Industry" released in November 2024 by the National Health Commission, National Administration of Traditional Chinese Medicine, and National Center for Disease Control and Prevention, the key AI scenarios in the medical field include: intelligent decision support for grassroots general practitioners, intelligent pre-diagnosis, intelligent medical record assistance generation, intelligent prescription pre-approval assistance, intelligent follow-up, and intelligent post-hospital management of patients. Comparatively, the layout of the Good Doctor Cloud Healthcare AI Good Doctor Diagnosis Support System in pre-diagnosis medical record generation, diagnosis assistance, intelligent prescription review, post-diagnosis health management, etc., aligns highly with the key scenarios listed in the official guidelines. This means that the company's current AI direction is not a marginal attempt deviating from regulatory and industry trends but rather entering into a landing direction encouraged by policies and with real needs in grassroots medical care. 4. What is truly worth observing is the continuity of AI commercialization The capital market abhors two types of misjudgments: one is treating AI as an all-encompassing narrative, overextending expectations, and the other is neglecting its transformative effect on the platform's form because it has not yet been fully realized. Unlike the startup companies that are currently hot in the market, relying excessively on AI without commercial capabilities, Good Doctor Cloud Healthcare focuses more on the integration of AI technology with usage scenarios, closely around the mission and vision of "comprehensively empowering grassroots medical care," leveraging the resources of nearly 700,000 grassroots medical terminals to apply the most advanced technology in the lowest-tier market, enabling practitioners and staff at grassroots medical institutions and grassroots LBX Pharmacy Chain Joint Stock to truly enjoy the convenience brought by technological progress, while also ensuring the profitability and sustainability of AI commercialization. The prospectus confirms that as of April 6, 2026, the AI Good Doctor Diagnosis Support System has covered: more than 29 provinces, 235 cities, over 520 counties/districts, reached over 8,500 grassroots medical institutions, served over 24,000 grassroots medical practitioners, with over 32 million outpatient visits and over 28 million generated medical records. In addition, from the day of its acquisition of Hangzhou Good Doctor Whole Visit to April 6, 2026, the company has accumulated over 3,500 orders for the AI Good Doctor Diagnosis Support System from customers, with contract amounts exceeding 91 million yuan. These numbers indicate two things: firstly, the AI system has established a wide range of scene coverage and is no longer in the stage of product testing or pilot demonstrations; secondly, it already has a certain commercial foundation, but the current scale is not enough to support the conclusion that "AI has become the core profit engine." In other words, the more prudent conclusion at this stage is not that "AI has fundamentally changed the company's financial structure" but rather: AI has begun to enter real scenarios, forming the rudiments of orders and revenue, and its subsequent value depends on commercial continuity, customer payment sustainability, and whether it can further improve the quality of profitability. This is where the market should truly focus next: - The speed at which the AI system coverage expands from over 8,500 grassroots medical institutions to a larger scale - Whether the number of orders and contract amounts can continue to grow - Whether AI capabilities can continue to be embedded in HIS, diagnostics, prescriptions, post-diagnosis management processes, enhancing customer stickiness - Whether AI-related revenue contribution can evolve from being a component of "other income" to becoming a clearer operational pillar 5. Conclusion If the market previously understood Good Doctor Cloud Healthcare more from the perspective of a "grassroots medical platform" or "internet medical service provider," the new information provided by this prospectus is that the company is evolving towards a medical health technology platform driven by AI. Its foundation still lies in three major mature business segments, with the main revenue currently coming from pharmaceutical direct supply and distribution services and specialized disease diagnosis and treatment solutions; however, at the same time, the company has begun embedding AI capabilities in the APP platform, HIS system, diagnostic testing, health management, and other areas, pushing the platform to upgrade from a transaction and service connector to a process participant, efficiency enhancer, and digital capability provider. Therefore, observation of Good Doctor Cloud Healthcare should no longer be confined to the old labels of the previous stage. What truly deserves forward-looking attention is not just short-term stock price sentiment but whether this company is leveraging grassroots medical scenarios, system capabilities, and AI tools to build a deeper, stronger platform barrier. From the coverage and order data revealed in the prospectus, this process has already begun.